CC
MURA

Centiva Capital’s Mural Oncology MURA Stock Holding History

Centiva Capital’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-203,706
Closed -$638K – 2150
2024
Q3 		$638K Sell
203,706
-20,825
-9% -$67.8K 0.01% 1085
2024
Q2 		$705K Buy
224,531
+126,946
+130% +$468K 0.01% 959
2024
Q1 		$477K Sell
97,585
-2,415
-2% -$11.7K 0.01% 1016
2023
Q4 		$592K Buy
+100,000
New +$402K 0.01% 875

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Centiva Capital's MURA Position: Q4 2024 in Review

Centiva Capital sold out of Mural Oncology (MURA) in Q4 2024, closing a stake of 203,706 shares — an estimated $638K sold.

Centiva Capital first reported a position in MURA in Q4 2023 and held it in 4 quarters. The position peaked at $705K in Q2 2024. 76 funds tracked by Wall St. Rank hold MURA as of Q4 2024.

  • Centiva Capital reported no remaining Mural Oncology position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 203,706 Mural Oncology shares in Q4 2024, an estimated $638K.
  • Centiva Capital first reported a position in Mural Oncology in Q4 2023 and held it in 4 quarters.
  • Centiva Capital's Mural Oncology position peaked at $705K in Q2 2024.
  • 76 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.